Pages that link to "Q107055182"
Jump to navigation
Jump to search
The following pages link to SARS-CoV-2 Delta variant (Q107055182):
Displayed 30 items.
- Deltacoronavirus (Q16955738) (← links)
- SARS-CoV-2 lineage B.1.617 (Q106581308) (← links)
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination (Q107233832) (← links)
- SARS-CoV-2 Delta plus variant (Q108004869) (← links)
- Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact (Q109048575) (← links)
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (Q109483323) (← links)
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study (Q110012529) (← links)
- SARS-CoV-2 Lineage AY.4.2 (Q110101454) (← links)
- SARS-CoV-2 Delmicron variant (Q110244250) (← links)
- Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study (Q110304615) (← links)
- (Q110322839) (redirect page) (← links)
- SARS-CoV-2 Lineage AY.20 (Q110487412) (← links)
- Deltacron (Q110488017) (← links)
- B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination (Q110492191) (← links)
- Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021 (Q110530563) (← links)
- Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion (Q110864826) (← links)
- SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion (Q111199839) (← links)
- Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals (Q111368088) (← links)
- SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough (Q111368089) (← links)
- Spatiotemporal patterns and progression of the Delta variant of COVID-19 and their health intervention linkages in Southeast Asia (Q111631517) (← links)
- Increased close proximity airborne transmission of the SARS-CoV-2 Delta variant (Q112267046) (← links)
- Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA (Q112558469) (← links)
- Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India (Q112573009) (← links)
- Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India) (Q112578701) (← links)
- Outbreak of SARS-CoV-2 B.1.617.2 (Delta Variant) in a Youth Camp Associated With Community Spread, Nebraska, June–July 2021 (Q114064538) (← links)
- In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta) (Q114782624) (← links)
- Wikidata:Property proposal/GISAID identifier (← links | edit)
- Wikidata:Property proposal/Nextstrain identifier (← links | edit)
- GISAID ID (P10193) (← links)
- Property talk:P10193 (← links | edit)